Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Equity

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment Retained Earnings	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest	Total
Balances (in shares) at Jun. 30, 2020			153,812,000
Balances at Jun. 30, 2020	$ (276)	$ (276)	$ 1,538	$ 419,383	$ 1,057,470	$ (97,199)		$ 1,381,192
Non-controlling interest in Eminence							$ 8,985	8,985
Net earnings					140,410		(825)	139,585
Other comprehensive income (loss)						39,908	103	$ 40,011
Share repurchases (in shares)			(480,000)					(480,000)
Share repurchases			$ (5)		(43,173)			$ (43,178)
Common stock issued for exercise of options (in shares)			2,293,000					2,509,000
Common stock issued for exercise of options			$ 23	62,085	(12,287)			$ 49,821
Common stock issued for restricted stock awards (in shares)			153,000
Common stock issued for restricted stock awards			$ 2	(2)	(7,057)			(7,057)
Cash dividends					(49,622)			(49,622)
Stock-based compensation expense				48,065				48,065
Common stock issued to employee stock purchase plan (in shares)			44,000
Common stock issued to employee stock purchase plan			$ 0	2,791				2,791
Employee stock purchase plan expense				917				917
Balances (in shares) at Jun. 30, 2021			155,822,000
Balances at Jun. 30, 2021			$ 1,558	533,239	1,085,465	(57,291)	8,263	1,571,234
Net earnings					272,051		(8,952)	263,099
Other comprehensive income (loss)						(17,909)	(70)	$ (17,979)
Share repurchases (in shares)			(1,577,000)					(1,576,952)
Share repurchases			$ (16)		(160,934)			$ (160,950)
Common stock issued for exercise of options (in shares)			2,282,000					2,450,000
Common stock issued for exercise of options			$ 23	74,354	(13,482)			$ 60,895
Common stock issued for restricted stock awards (in shares)			89,000
Common stock issued for restricted stock awards			$ 1	(1)	(9,978)			(9,978)
Cash dividends					(50,185)			(50,185)
Stock-based compensation expense				41,208				41,208
Common stock issued to employee stock purchase plan (in shares)			28,000
Common stock issued to employee stock purchase plan			$ 0	2,694				2,694
Employee stock purchase plan expense				973				$ 973
Balances (in shares) at Jun. 30, 2022			156,644,000					156,644,212
Balances at Jun. 30, 2022			$ 1,566	652,467	1,122,937	(75,200)	(759)	$ 1,701,011
Reclassification of cumulative translation adjustment for Eminence to non-operating income						152	(33)	119
Elimination of noncontrolling equity interest from sale of Eminence							613	613
Net earnings					285,263		$ 179	285,442
Other comprehensive income (loss)						8,984		8,984
Other comprehensive income (loss)								$ 9,103
Share repurchases (in shares)			(222,000)					(222,000)
Share repurchases			$ (2)		(19,560)			$ (19,562)
Common stock issued for exercise of options (in shares)			1,083,000					1,578,000
Common stock issued for exercise of options			$ 10	24,942	(22,163)			$ 2,789
Common stock issued for restricted stock awards (in shares)			63,000
Common stock issued for restricted stock awards			$ 1	(1)	(6,731)			(6,731)
Cash dividends					(50,285)			(50,285)
Stock-based compensation expense				38,315				38,315
Common stock issued to employee stock purchase plan (in shares)			74,000
Common stock issued to employee stock purchase plan			$ 1	4,905				4,906
Employee stock purchase plan expense				915				$ 915
Balances (in shares) at Jun. 30, 2023			157,642,000					157,641,914
Balances at Jun. 30, 2023			$ 1,576	$ 721,543	$ 1,309,461	$ (66,064)		$ 1,966,516